Ilunocitinib (Zenrelia): Rapid Itch Relief for Dogs with Allergic Dermatitis

Fast, Steroid-Free Itch Relief for Dogs with Allergic Dermatitis

If your dog is constantly scratching, biting, and rubbing — unable to rest, their skin raw and inflamed — you know how distressing allergic dermatitis can be for both of you. Ilunocitinib (Zenrelia) is a next-generation JAK inhibitor that breaks the itch-scratch-inflammation cycle quickly and effectively, without the side effects associated with long-term steroid use.

How Ilunocitinib Works

Ilunocitinib is a Janus Kinase (JAK) inhibitor that targets the intracellular signaling pathways responsible for triggering itch and allergic inflammation. By blocking JAK enzymes, it interrupts the cascade of inflammatory signals that cause pruritus — delivering rapid relief at the molecular level rather than simply masking symptoms.

Why Choose Ilunocitinib?

• Rapid itch relief — fast-acting JAK inhibition that begins reducing pruritus quickly after dosing
• Steroid-free formula — effective allergy management without the long-term risks associated with corticosteroids
• Targets the root cause — blocks the JAK signaling pathway driving allergic inflammation, not just the symptoms
• Licensed veterinary drug — a Class I veterinary medicine licensed by Elanco for use in dogs
• Breaks the itch-scratch cycle — helps prevent secondary skin damage caused by persistent scratching and self-trauma

What Ilunocitinib Treats

• Allergic dermatitis — skin inflammation and itching triggered by allergic reactions
• Atopic dermatitis — chronic itching caused by environmental allergens such as pollen, dust mites, and mold

Recommended Use

Ilunocitinib is a veterinary-prescribed medication. Dosage is determined by your veterinarian based on your dog's weight and condition. Use under professional supervision, with periodic reassessment to monitor skin health and treatment response. Not for use in cats.